Shanchao Zhao

16PUBLICATIONS
152CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosisProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 07, 2026
APOE+ macrophages and POSTN+CAFs form immune-exclusion niche driving immunotherapy resistance in clear-cell renal carcinoma.

|Jul 01, 2026
FOXQ1 activates GLT8D2 to enhance CCL2 N-glycosylation and promote prostate cancer bone metastasis.

|Feb 17, 2026
The FOSB-IGFBP5-IGF-1 axis: a novel regulatory pathway that suppresses prostate cancer growth.

Jun Huang, Sheng-Dong Ge, Ling-Lan Zhao

|Nov 02, 2025
CAD is Associated with Cancer Prognosis and Promotes Enzalutamide Resistance in Prostate Cancer.

Bing-Xue Ma, Yi-You Mao, Ze-Fan Zhang

|Aug 07, 2025
Automatic recognition of adrenal incidentalomas using a two-stage cascade network: a multicenter study.

Xiao Xie, Sheng-Xiao Ma, Xiang-De Luo

|Aug 01, 2025
New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic.

Maoping Cai, Fengtao Zheng, Yang-Zi Ren

Pageof 3

Frequent Collaborators

2 joint publications

Ninghan Feng

2 joint publications

Mingkun Chen

2 joint publications

Zhiyue Xie

1 joint publications

Bin Xu